Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • SOXS vs GSK✓SelectedUSD · GSKSOXS vs GSK performance historyLatest closeAs of+8.12%11/19
Stock and ETF performance explorer

SOXS vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-99.6%
GSK return
+53.5%
Excess return
-153.1%
Maximum drawdown
-99.8%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+8.1%-1.6%+9.7%+8.2%
7D+38.1%-4.7%+42.8%+38.3%
30D+34.0%-4.7%+38.7%+34.0%
3M+35.9%-8.8%+44.6%+34.6%
6M-34.9%-4.6%-30.2%-35.3%
YTD-89.6%+1.0%-90.6%-89.4%
1Y-92.0%+6.9%-98.9%-91.7%
All-99.6%+53.5%-153.1%-99.5%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling